Guo M - Search Results

1

MafG/MYH9-LCN2 axis promotes liver fibrosis through inhibiting ferroptosis of hepatic stellate cells.

Deng Y, Lu L, Zhu D, Zhang H, Fu Y, Tan Y, Tan X, Guo M, Zhang Y, Yang H, Yang B, Liu T, Chen Y. Deng Y, et al. Among authors: guo m. Cell Death Differ. 2024 Sep;31(9):1127-1139. doi: 10.1038/s41418-024-01322-5. Epub 2024 Jun 13. Cell Death Differ. 2024. PMID: 38871948

2

A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma.

Feng Y, Zhang Y, Cai Y, Liu R, Lu M, Li T, Fu Y, Guo M, Huang H, Ou Y, Chen Y. Feng Y, et al. Among authors: guo m. Cell Death Dis. 2020 Feb 3;11(2):89. doi: 10.1038/s41419-020-2278-6. Cell Death Dis. 2020. PMID: 32015333 Free PMC article.

3

Amyloid aggregates induced by the p53-R280T mutation lead to loss of p53 function in nasopharyngeal carcinoma.

Li J, Guo M, Chen L, Chen Z, Fu Y, Chen Y. Li J, et al. Among authors: guo m. Cell Death Dis. 2024 Jan 11;15(1):35. doi: 10.1038/s41419-024-06429-8. Cell Death Dis. 2024. PMID: 38212344 Free PMC article.

4

p53 amyloid aggregation in cancer: function, mechanism, and therapy.

Li J, Guo M, Chen L, Chen Z, Fu Y, Chen Y. Li J, et al. Among authors: guo m. Exp Hematol Oncol. 2022 Sep 28;11(1):66. doi: 10.1186/s40164-022-00317-7. Exp Hematol Oncol. 2022. PMID: 36171607 Free PMC article. Review.

5

Targeting p53 pathways: mechanisms, structures, and advances in therapy.

Wang H, Guo M, Wei H, Chen Y. Wang H, et al. Among authors: guo m. Signal Transduct Target Ther. 2023 Mar 1;8(1):92. doi: 10.1038/s41392-023-01347-1. Signal Transduct Target Ther. 2023. PMID: 36859359 Free PMC article. Review.

6

Predicting miRNA-Disease Associations by Combining Graph and Hypergraph Convolutional Network.

Liang X, Guo M, Jiang L, Fu Y, Zhang P, Chen Y. Liang X, et al. Among authors: guo m. Interdiscip Sci. 2024 Jun;16(2):289-303. doi: 10.1007/s12539-023-00599-3. Epub 2024 Jan 29. Interdiscip Sci. 2024. PMID: 38286905

7

Structural Basis for DNA Recognition by FOXG1 and the Characterization of Disease-causing FOXG1 Mutations.

Dai S, Li J, Zhang H, Chen X, Guo M, Chen Z, Chen Y. Dai S, et al. Among authors: guo m. J Mol Biol. 2020 Nov 20;432(23):6146-6156. doi: 10.1016/j.jmb.2020.10.007. Epub 2020 Oct 13. J Mol Biol. 2020. PMID: 33058871

8

Targeting MCL-1 in cancer: current status and perspectives.

Wang H, Guo M, Wei H, Chen Y. Wang H, et al. Among authors: guo m. J Hematol Oncol. 2021 Apr 21;14(1):67. doi: 10.1186/s13045-021-01079-1. J Hematol Oncol. 2021. PMID: 33883020 Free PMC article. Review.

9

Structural basis of the specificity and interaction mechanism of Bmf binding to pro-survival Bcl-2 family proteins.

Wang H, Guo M, Wei H, Chen Y. Wang H, et al. Among authors: guo m. Comput Struct Biotechnol J. 2023 Jul 21;21:3760-3767. doi: 10.1016/j.csbj.2023.07.017. eCollection 2023. Comput Struct Biotechnol J. 2023. PMID: 37560128 Free PMC article.

10

Structural insight into the ligand binding mechanism of aryl hydrocarbon receptor.

Dai S, Qu L, Li J, Zhang Y, Jiang L, Wei H, Guo M, Chen X, Chen Y. Dai S, et al. Among authors: guo m. Nat Commun. 2022 Oct 20;13(1):6234. doi: 10.1038/s41467-022-33858-w. Nat Commun. 2022. PMID: 36266304 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,723 results

Search Page

Filters